Weiss Asset Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Weiss Asset Management’s Portfolio PRVL Stock Details PRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-112,827	Closed	-$2.6M	–	703
2020 Q4	$2.6M	Buy	+112,827	New	+$1.43M	0.11%	148

Weiss Asset Management's PRVL Position: Q1 2021 in Review

Weiss Asset Management sold out of Prevail Therapeutics Inc. Common Stock (PRVL) in Q1 2021, closing a stake of 112,827 shares — an estimated $2.6M sold.

Weiss Asset Management first reported a position in PRVL in Q4 2020 and held it in 1 quarter. The position peaked at $2.6M in Q4 2020. 0 funds tracked by Wall St. Rank hold PRVL as of Q1 2021.

Weiss Asset Management reported no remaining Prevail Therapeutics Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Weiss Asset Management sold 112,827 Prevail Therapeutics Inc. Common Stock shares in Q1 2021, an estimated $2.6M.
Weiss Asset Management first reported a position in Prevail Therapeutics Inc. Common Stock in Q4 2020 and held it in 1 quarter.
Weiss Asset Management's Prevail Therapeutics Inc. Common Stock position peaked at $2.6M in Q4 2020.
0 funds tracked by Wall St. Rank held Prevail Therapeutics Inc. Common Stock as of Q1 2021.

Based on Weiss Asset Management's 13F filing for Q1 2021, filed 14 May 2021.